Researchers are exploring Manfredokimab AK120, a novel interleukin 17A (IL-17A) antagonist, regarding treatment avenue for those diagnosed with ulcerative colitis. Early clinical trials suggest that this drug https://ztndz.com/story28780908/manfidokimab-ak120-a-promising-possibility-for-ulcerative-colitis